|
End-of-day quote
Shenzhen S.E.
2026-08-20
|
5-day change | 1st Jan Change | ||
| 54.42 CNY | +4.33% |
|
-1.43% | -8.80% |
| Market Cap | 4.3B 639M 547M 510M 468M 880M 61.13B 897M 6.05B 2.36B 30.63B 2.4B 2.35B 101B | P/E 2024 |
-22.7x | P/E 2025 | -46.3x |
|---|---|---|---|---|---|
| Enterprise Value | 4.62B 687M 589M 549M 504M 947M 65.77B 965M 6.51B 2.54B 32.96B 2.58B 2.52B 109B | EV / Sales 2024 |
6.46x | EV / Sales 2025 | 32.7x |
| Free-Float |
30.57% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | +4.33% | ||
| 1 week | -1.43% | ||
| Current month | +9.23% | ||
| 1 month | +10.95% | ||
| 3 months | -37.66% | ||
| 6 months | -12.34% | ||
| Current year | -8.80% |
| 1 week | 51.5 |  | 56.84 |
| 1 month | 44.55 | | 58.49 |
| Current year | 44.55 | | 98.29 |
| 1 year | 37.2 | | 98.29 |
| 3 years | 12.6 | | 98.29 |
| 5 years | 12.6 | | 98.29 |
| 10 years | 12.6 | | 98.29 |
| Manager | Title | Age | Since |
|---|---|---|---|
Yong Deng
CEO | Chief Executive Officer | 60 | 2018-11-30 |
Chao Li
DFI | Director of Finance/CFO | 47 | 2017-04-30 |
Fen Jin
DFI | Director of Finance/CFO | 46 | 2017-11-30 |
| Director | Title | Age | Since |
|---|---|---|---|
Yong Deng
CHM | Chairman | 60 | 2017-11-30 |
Shao Zhong Zhang
BRD | Director/Board Member | 70 | 2020-02-20 |
Qin Deng
BRD | Director/Board Member | 58 | 2020-02-20 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +4.33% | -1.43% | +31.51% | +103.82% | 612M | |
| -2.81% | +2.93% | +76.40% | +127.73% | 1,141B | |
| -2.21% | +2.02% | +49.50% | +55.01% | 659B | |
| -1.56% | +4.39% | +25.19% | +74.39% | 470B | |
| +1.20% | +2.62% | +41.69% | +45.78% | 366B | |
| -0.61% | +2.10% | +23.43% | +41.34% | 302B | |
| +0.32% | +3.25% | +0.94% | +13.42% | 254B | |
| -1.95% | +3.80% | +46.31% | +65.66% | 239B | |
| -1.10% | -0.70% | -14.31% | -52.66% | 207B | |
| -2.82% | +3.84% | +20.81% | +89.04% | 183B | |
| Average | -0.72% | +2.49% | +30.15% | +56.35% | 382.16B | |
| Weighted average by Cap. | -1.64% | +3.12% | +43.48% | +70.86% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 241M 35.78M 30.63M 28.58M 26.22M 49.28M 3.42B 50.25M 339M 132M 1.72B 134M 131M 5.68B | 154M 22.92M 19.63M 18.31M 16.8M 31.57M 2.19B 32.19M 217M 84.68M 1.1B 86.07M 84.2M 3.64B |
| Net income | -62.67M -9.32M -7.98M -7.44M -6.83M -12.83M -892M -13.09M -88.3M -34.42M -447M -34.98M -34.22M -1.48B | -102M -15.19M -13.01M -12.13M -11.13M -20.92M -1.45B -21.33M -144M -56.12M -728M -57.04M -55.8M -2.41B |
| Net Debt | 135M 20.02M 17.15M 16M 14.68M 27.58M 1.92B 28.12M 190M 73.98M 960M 75.19M 73.55M 3.18B | 327M 48.58M 41.59M 38.81M 35.61M 66.91M 4.65B 68.23M 460M 179M 2.33B 182M 178M 7.71B |
Employees
461
Sector
Pharmaceuticals
Calendar
Aug. 26
Earnings release - Q2 2026
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-08-20 | CN¥54.42 | +4.33% | 1,442,123 |
| 26-08-19 | CN¥52.16 | -6.56% | 988,716 |
| 26-08-18 | CN¥55.82 | -1.69% | 611,400 |
| 26-08-17 | CN¥56.78 | +3.35% | 1,085,200 |
| 26-08-14 | CN¥54.94 | -0.49% | 987,000 |
- Stock Market
- Stocks
- 301075 Stock
Select your edition
All financial news and data tailored to specific country editions
